Infliximab first-line treatment for Crohn’s disease in children
Infliximab first-line treatment for Crohn’s disease in children
Article:
Gut. 2022 Jan;71(1):34-42.
First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn’s disease: an open-label multicentre randomised controlled trial
Reviewer: Dr. Erik Clutter